Sumitomo Pharma Co Ltd - Company Profile
Powered by 
All the data and insights you need on Sumitomo Pharma Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Sumitomo Pharma Co Ltd Strategy Report
- Understand Sumitomo Pharma Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Sumitomo Pharma Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| WO2022191252A1 | Application | METHOD FOR PRODUCING CYSTEINE KNOT PROTEIN | September 15, 2022 | |
| AU2016320991B2 | Grant | Method for producing retinal pigment epithelial cells | A61K35/30; A61K35/545; A61L27/00; A61P27/02; C12N2500/90; C12N2501/115; C12N2501/15; C12N2501/155; C12N2501/41; C12N2501/727; C12N2501/999; C12N2506/03; C12N2506/45; C12N5/0621; C12Q1/02; G01N33/5014; G01N33/5044; G01N33/5058 | September 15, 2022 |
| WO2022191253A1 | Application | METHOD FOR PRODUCING FUSION PROTEIN | September 15, 2022 | |
| WO2022191332A1 | Application | PREDICTION OF AMOUNT OF IN VIVO DOPAMINE ETC., AND APPLICATION THEREOF | September 15, 2022 | |
| EP3231867B1 | Grant | TUMORANTIGENPEPTID | A61K2039/572; A61K2039/82; A61K39/0011; A61K39/00118; A61K48/00; A61P35/00; C07K14/47; C07K14/4748; C07K16/2833; C07K16/30; C07K2317/34; C07K7/06; C07K7/08; C12N5/0638; C12Q1/68; C12Q1/6886; C12Q2600/136; C12Q2600/158; C12Q2600/178; G01N2333/46; G01N2333/70539; G01N2500/00; G01N33/5011; G01N33/5088; G01N33/574; G01N33/57484 | September 14, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer